Compare KNSA & HASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KNSA | HASI |
|---|---|---|
| Founded | 2015 | 1981 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.2B |
| IPO Year | 2018 | 2012 |
| Metric | KNSA | HASI |
|---|---|---|
| Price | $45.91 | $36.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $55.29 | $42.38 |
| AVG Volume (30 Days) | 672.2K | ★ 736.7K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 4.77% |
| EPS Growth | ★ 225.00 | N/A |
| EPS | 0.75 | ★ 1.41 |
| Revenue | ★ $677,564,000.00 | $400,502,000.00 |
| Revenue This Year | $38.01 | $61.10 |
| Revenue Next Year | $17.42 | $250.69 |
| P/E Ratio | $61.35 | ★ $25.24 |
| Revenue Growth | ★ 60.09 | 4.41 |
| 52 Week Low | $18.26 | $21.98 |
| 52 Week High | $49.12 | $40.01 |
| Indicator | KNSA | HASI |
|---|---|---|
| Relative Strength Index (RSI) | 51.92 | 52.33 |
| Support Level | $39.96 | $35.26 |
| Resistance Level | $48.14 | $37.22 |
| Average True Range (ATR) | 1.79 | 0.98 |
| MACD | -0.15 | -0.06 |
| Stochastic Oscillator | 56.63 | 66.98 |
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
HA Sustainable Infrastructure Capital Inc is an investor in sustainable infrastructure assets advancing the energy transition. Its investment is focused on actively partnering with clients to deploy capital in income-generating real assets that are supported by long-term recurring cash flows. This enabled to the generation of attractive risk-adjusted returns and provided stockholders with diversified exposure to the energy transition.